サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1659413

分子生物学用酵素・キット・試薬の世界市場

Molecular Biology Enzymes and Kits & Reagents

出版日
ページ情報
英文 89 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
分子生物学用酵素・キット・試薬の世界市場
出版日: 2025年02月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

分子生物学用酵素およびキット・試薬の世界市場は2030年までに705億米ドルに達する

2024年に324億米ドルと推定される分子生物学用酵素・キット・試薬の世界市場は、2030年には705億米ドルに達し、分析期間2024-2030年のCAGRは13.9%で成長すると予測されます。本レポートで分析したセグメントの1つである分子生物学キット＆試薬は、CAGR14.6％を記録し、分析期間終了時には648億米ドルに達すると予測されます。分子生物学酵素分野の成長率は、分析期間中CAGR 7.0％と推定されます。

米国市場は90億米ドルと推定、中国はCAGR13.2%で成長すると予測

米国の分子生物学酵素およびキット・試薬市場は、2024年に90億米ドルと推定されます。世界第2位の経済大国である中国は、2024-2030年のCAGRを13.2%として、2030年までに108億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.0％と11.5％と予測されています。欧州では、ドイツがCAGR約9.5％で成長すると予測されています。

世界の分子生物学用酵素およびキット・試薬市場- 主要動向と市場促進要因のまとめ

分子生物学酵素、キット、試薬はどのように調査に革命を起こしているか？

分子生物学の酵素、キット、試薬は、DNA配列決定、ポリメラーゼ連鎖反応（PCR）、遺伝子クローニング、タンパク質分析など、さまざまな研究用途で使用される不可欠なツールです。これらの製品は、ライフサイエンス、バイオテクノロジー、製薬研究において重要な役割を果たしており、科学者は遺伝物質の構造、機能、相互作用を研究することができます。DNAポリメラーゼ、制限酵素、リガーゼなどの分子生物学用酵素は、核酸の操作と分析を容易にし、病気の解明、新しい治療法の開発、遺伝子工学の進歩に不可欠です。分子生物学用酵素、キット、試薬の市場は、ゲノミクス、プロテオミクス、個別化医療の研究活動の増加により拡大しています。遺伝子疾患の解明と標的治療法の開発に注目が集まる中、高度な分子生物学ツールに対する需要が高まっています。製薬企業や研究機関は、創薬を加速し診断技術を向上させるために分子生物学研究に多額の投資を行っており、市場の成長をさらに後押ししています。

分子生物学酵素、キット、試薬市場を牽引する動向とは？

分子生物学用酵素、キット、試薬市場に影響を与える主な動向には、次世代シーケンサー（NGS）の台頭、バイオテクノロジーとライフサイエンス研究の成長、個別化医療への注目の高まりなどがあります。NGS技術はDNA配列のハイスループット解析を可能にすることでゲノム研究に革命をもたらし、分子生物学用酵素・試薬の需要を牽引しています。NGSプラットフォームと技術の急速な進歩は、企業がシーケンス用途に合わせた特殊な酵素やキットを開発する機会を生み出しています。個人の遺伝的体質に基づいて治療をカスタマイズする個別化医療が重視されるようになったことも、分子生物学ツールの需要を押し上げています。研究開発はこれらのツールを使って遺伝子の変異を研究し、精密治療を開発しています。さらに、バイオテクノロジー産業の拡大により研究開発資金が増加し、高品質の分子生物学製品に対する需要が高まっていることも、市場開拓に貢献しています。

市場セグメンテーションは分子生物学の酵素、キット、試薬にどのような影響を与えるか？

製品カテゴリーには酵素、キット、試薬があり、酵素は様々な分子生物学的手法で幅広く使用されているため、最大のシェアを占めています。これらの製品の用途は、研究、診断、治療開発など多岐にわたり、研究室や学術機関が主なユーザーです。エンドユーザー・セグメントには、学術・研究機関、病院・診断センター、製薬・バイオテクノロジー企業が含まれます。製薬・バイオテクノロジー分野は、創薬・開発への投資が増加しているため、著しい成長を遂げています。地域的には、高度な研究インフラとライフサイエンスへの多額の資金提供により、北米が市場を独占しています。一方、アジア太平洋地域は、研究活動の増加とバイオテクノロジー開発に対する政府の支援により、急速な成長を遂げています。

分子生物学用酵素、キット、試薬市場の成長を促進する要因は？

分子生物学用酵素、キット、試薬市場の成長は、遺伝子研究需要の高まり、分子生物学技術の進歩、個別化医療への注目の高まりなど、いくつかの要因によって牽引されています。ゲノムおよびプロテオミクス研究の拡大が分子生物学ツールの需要を押し上げています。NGSやその他の分子技術の開発は、特殊な製品を開発する機会を生み出しています。さらに、精密医療の傾向の高まりが、分子生物学的酵素、キット、試薬を標的治療や診断の開発に使用することを後押ししています。

セグメント

製品（キット・試薬、酵素）;用途（PCR、シークエンシング、クローニング、エピジェネティクス、その他用途）;最終用途（学術・研究、製薬・バイオテクノロジー、病院・診断、その他最終用途）

調査対象企業の例（注目の33社）

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzymatics
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Merck KGaA
  • New England Biolabs
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Co. LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22322

Global Molecular Biology Enzymes and Kits & Reagents Market to Reach US$70.5 Billion by 2030

The global market for Molecular Biology Enzymes and Kits & Reagents estimated at US$32.4 Billion in the year 2024, is expected to reach US$70.5 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Molecular Biology Kits & Reagents, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$64.8 Billion by the end of the analysis period. Growth in the Molecular Biology Enzymes segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.0 Billion While China is Forecast to Grow at 13.2% CAGR

The Molecular Biology Enzymes and Kits & Reagents market in the U.S. is estimated at US$9.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.8 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Molecular Biology Enzymes and Kits & Reagents Market - Key Trends and Drivers Summarized

How Are Molecular Biology Enzymes, Kits & Reagents Revolutionizing Research?

Molecular biology enzymes, kits, and reagents are essential tools used in various research applications, including DNA sequencing, polymerase chain reactions (PCR), gene cloning, and protein analysis. These products play a critical role in life sciences, biotechnology, and pharmaceutical research, enabling scientists to study the structure, function, and interactions of genetic material. Molecular biology enzymes, such as DNA polymerases, restriction enzymes, and ligases, facilitate the manipulation and analysis of nucleic acids, which is crucial for understanding diseases, developing new treatments, and advancing genetic engineering. The market for molecular biology enzymes, kits, and reagents is expanding due to increasing research activities in genomics, proteomics, and personalized medicine. With the growing focus on understanding genetic disorders and developing targeted therapies, there is a rising demand for advanced molecular biology tools. Pharmaceutical companies and research institutions are investing heavily in molecular biology research to accelerate drug discovery and improve diagnostic techniques, further fueling the market's growth.

What Trends Are Driving the Molecular Biology Enzymes, Kits & Reagents Market?

Key trends influencing the molecular biology enzymes, kits, and reagents market include the rise of next-generation sequencing (NGS), the growth of biotechnology and life sciences research, and the increasing focus on personalized medicine. NGS technologies have revolutionized genomics research by enabling high-throughput analysis of DNA sequences, driving the demand for molecular biology enzymes and reagents. The rapid advancements in NGS platforms and techniques are creating opportunities for companies to develop specialized enzymes and kits tailored for sequencing applications. The growing emphasis on personalized medicine, which involves tailoring medical treatments based on an individual's genetic makeup, is also boosting the demand for molecular biology tools. Researchers are using these tools to study genetic variations and develop precision therapies. Additionally, the expansion of the biotechnology industry, with increased funding for research and development, is further contributing to market growth by driving demand for high-quality molecular biology products.

How Do Market Segments Impact Molecular Biology Enzymes, Kits & Reagents?

Product categories include enzymes, kits, and reagents, with enzymes accounting for the largest share due to their extensive use in various molecular biology techniques. Applications of these products span across research, diagnostics, and therapeutic development, with research laboratories and academic institutions being the primary users. The end-user segment includes academic and research institutes, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology segment is witnessing significant growth due to increasing investments in drug discovery and development. Geographically, North America dominates the market due to advanced research infrastructure and substantial funding for life sciences. Meanwhile, the Asia-Pacific region is experiencing rapid growth, driven by increasing research activities and government support for biotechnology development.

What Factors Are Driving the Growth in the Molecular Biology Enzymes, Kits & Reagents Market?

The growth in the molecular biology enzymes, kits, and reagents market is driven by several factors, including the rising demand for genetic research, advancements in molecular biology techniques, and the increasing focus on personalized medicine. The expansion of genomics and proteomics research is boosting the demand for molecular biology tools. Advancements in NGS and other molecular techniques are creating opportunities for the development of specialized products. Furthermore, the growing trend of precision medicine is encouraging the use of molecular biology enzymes, kits, and reagents for the development of targeted therapies and diagnostics.

SCOPE OF STUDY:

The report analyzes the Molecular Biology Enzymes and Kits & Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits & Reagents, Enzymes); Application (PCR, Sequencing, Cloning, Epigenetics, Other Applications); End-Use (Academic & Research, Pharma & Biotech, Hospital & Diagnostics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzymatics
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Merck KGaA
  • New England Biolabs
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Co. LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Molecular Biology Enzymes and Kits & Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Genomics and Proteomics Research Spurs Growth in Molecular Biology Enzymes and Kits & Reagents Market
    • Technological Advancements in High-Fidelity Enzymes and PCR Kits Strengthen Business Case for Adoption
    • Growing Focus on Personalized Medicine and Diagnostic Applications Expands Addressable Market
    • Expansion of Molecular Biology Enzymes and Kits in Pharmaceutical and Biotechnology Industries Fuels Market Growth
    • Increasing Adoption of NGS (Next-Generation Sequencing) and CRISPR Technologies Expands Market Opportunities
    • Technological Innovations in Recombinant Enzymes and High-Throughput Kits Propel Market Expansion
    • Rising Focus on Enhancing Accuracy and Reproducibility in Molecular Experiments Drives Demand for Enzymes and Kits
    • Growing Use of Molecular Biology Enzymes and Kits in Agriculture and Food Safety Testing Expands Market Potential
    • Focus on Reducing Experiment Time and Improving Workflow Efficiency Strengthens Market for Molecular Biology Reagents
    • Rising Adoption of Molecular Biology Enzymes in Cancer Research and Biomarker Discovery Expands Addressable Market
    • Technological Advancements in Point-of-Care Molecular Diagnostic Kits Propel Market Growth
    • Expansion of Molecular Biology Reagents in Environmental and Microbial Studies Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Academic & Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospital & Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Molecular Biology Enzymes and Kits & Reagents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION